Be part of the knowledge.™

Ophthalmology

52

LikeLikedUnlike

16-30 of 75

Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma
MinuteCE®
Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma
- Janis T. Eells, Ph.D.
1.00 program credits
Real-World Evidence of Photobiomodulation Efficacy in Ocular Indications
MinuteCE®
Real-World Evidence of Photobiomodulation Efficacy in Ocular Indications
- Marion Munk, MD, Ph.D
- David Boyer, MD
1.00 program credits
Anatomical Outcomes from the LIGHTSITE III Trial
MinuteCE®
Anatomical Outcomes from the LIGHTSITE III Trial
- Diana V. Do, MD
- David Boyer, MD
1.00 program credits
Insights and Updates: New Data on Next-Generation Retinal Treatments
CME/CE
Insights and Updates: New Data on Next-Generation Retinal Treatments
- Durga Borkar, MD, MMCi
- Veeral Sheth, MD, MBA, FASRS, FACS
0.50 credits
Retina Case Review: Translating the Data Into Care
CME/CE
Retina Case Review: Translating the Data Into Care
- Durga Borkar, MD, MMCi
- Veeral Sheth, MD, MBA, FASRS, FACS
0.25 credits
Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
CME/CE Broadcast Replay
Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
- Arshad M. Khanani MD, MA, FASRS
- Veeral Sheth, MD, MBA, FASRS, FACS
- Lejla Vajzovic, MD, FASRS
1.00 credits
advertisement
Presbyopia-Correcting Drops: The Importance of Patient Selection
CME/CE
Presbyopia-Correcting Drops: The Importance of Patient Selection
- Christina Y. Weng, MD, MBA, FASRS
- Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
0.25 credits
The Role of Presbyopia-Correcting Drops
CME/CE
The Role of Presbyopia-Correcting Drops
- Mark T. Dunbar, OD, FAAO
- David Eichenbaum, MD
0.25 credits
Real-World Adaptation of Trial Protocols
MinuteCE®
Real-World Adaptation of Trial Protocols
- Roger A. Goldberg, MD, MBA
- Ehsan Rahimy, MD
1.00 program credits
Early Fluid Resolution – A Key to Long-Term Success
MinuteCE®
Early Fluid Resolution – A Key to Long-Term Success
- Roger A. Goldberg, MD, MBA
- Ehsan Rahimy, MD
1.00 program credits
Signs of Progress: PED as a Predictor of Disease and Outcomes
MinuteCE®
Signs of Progress: PED as a Predictor of Disease and Outcomes
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credits
Beyond Durability - What Biomarkers Reveal About Disease Control
MinuteCE®
Beyond Durability - What Biomarkers Reveal About Disease Control
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credits
advertisement
Predicting Durability: Where Are We Now?
MinuteCE®
Predicting Durability: Where Are We Now?
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credits
Macular Leakage: Indicator of Vascular Stability
MinuteCE®
Macular Leakage: Indicator of Vascular Stability
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credits
MinuteCE®
Biomarking the Difference: How Second-Generation Therapies are Changing the Game
- Justis P. Ehlers, MD, FASRS
- Roger A. Goldberg, MD, MBA
- Jennifer, I. Lim, MD, FASRS, FARVO
- Ehsan Rahimy, MD
1.00 credits 10 episodes

Program Chapters

Segment Chapters

Playlist:

Recommended